HolderBook

VERACYTE INC (VCYT)

Institutional ownership reported to the SEC as of Q3 2026, across 32 quarters.

11
Reporting holders
$119.7M
Reported value
0.0%
Calls
0.0%
Puts
-361
Holder change

Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.

Holders

Download these holders as CSV

FilerValueShares Their book Held Change
CONGRESS ASSET MANAGEMENT CO$90.0M1,954,1980.58%newNEW
Artemis Investment Management LLP$29.6M643,0210.26%2q+0.6%+$188.2K
GAMMA Investing LLC$60.0K1,3040.00%12q+16.3%+$8.4K
Farther Finance Advisors, LLC$25.0K5430.00%16q-39.8%-$16.5K
Versant Capital Management, Inc$12.8K2790.00%10q+6.9%
GK Wealth Management LLC$8.1K1770.00%newNEW
MassMutual Private Wealth & Trust, FSB$3.8K820.00%11qHELD
TOTH FINANCIAL ADVISORY CORP$2.8K600.00%newNEW
Retirement Wealth Solutions LLC$921200.00%5q-54.5%-$1.1K
GILPIN WEALTH MANAGEMENT, LLC$691150.00%4qHELD
Davis Capital Management$9220.00%2q-50.0%

What the company announced

Form 8-K filings from the last 120 days, showing only the items worth a reader's attention. Earnings releases, exhibit attachments and general disclosures are filed constantly and are left out. Filed is when the SEC received it; event is the date the company says the thing happened.

FiledEvent dateWhatSource
2026-09-142026-09-10Acquisition or disposal completed Material agreement enteredfiling

What the insiders did

Open market purchases and sales reported on Form 4 in the last 180 days. Grants, option exercises and shares surrendered to cover tax are left out: they are compensation rather than a decision to buy or sell. Where a broker filled one order in tranches the lines are summed, because it was one decision.

Officers and directors

DateInsiderRoleSideSharesValue
2026-06-04Stapley MarcChief Executive OfficerSold138,051$6.9M
2026-05-22Wygant JonathanVP, Chief Accounting OfficerSold24,000$1.1M
2026-06-04Leite JohnGlobal Chief Commercial OffSold13,975$699.7K
2026-09-04Febbo Phillip G.Chief Scientific & Med OfficerSold13,110$564.4K ×2
2026-05-20EPSTEIN ROBERT SDirectorSold10,000$440.1K
2026-05-06McGuire AnnieSVP, General CounselSold10,204$398.2K ×2
2026-09-14Holstein JensDirectorSold5,000$204.7K
2026-06-18EASTHAM KARINDirectorSold3,729$197.2K ×2
2026-06-04Chambers RebeccaChief Financial OfficerSold3,561$177.1K ×2
2026-09-21Leite JohnGlobal Chief Commercial OffSold4,015$160.6K
2026-06-04McGuire AnnieEVP, General CounselSold3,176$158.0K ×2
2026-09-04Chambers RebeccaChief Financial OfficerSold3,652$157.4K ×2

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q3 202611$119.7M2,599,7013330.0%
Q2 2026372$5.6B95,687,962771331150.3%
Q1 2026336$2.9B88,470,68043138940.3%
Q4 2025328$3.7B88,206,90252991100.2%
Q3 2025298$3.1B90,260,1316890860.1%
Q2 2025278$2.3B85,398,1093495990.0%
Q1 2025288$2.5B84,765,28825109990.0%
Q4 2024317$3.3B82,356,048421001140.3%
Q3 2024291$2.8B82,367,7467385910.2%
Q2 2024241$1.8B82,540,6102687790.1%
Q1 2024246$1.8B83,219,13236113630.2%
Q4 2023249$2.2B78,051,8922674980.2%
Q3 2023234$1.7B76,925,0042688730.3%
Q2 2023230$2.0B77,124,2152285760.0%
Q1 2023230$1.7B78,891,9663391570.1%
Q4 2022222$1.8B76,204,3104571680.1%
Q3 2022206$1.3B77,335,0553175640.4%
Q2 2022193$1.5B77,505,9572682510.3%
Q1 2022200$2.1B77,504,3412178650.2%
Q4 2021214$3.1B75,885,5272581600.1%
Q3 2021213$3.5B75,099,7092770720.0%
Q2 2021215$2.9B72,859,2543376660.1%
Q1 2021234$3.9B73,242,1593992730.4%
Q4 2020221$3.2B65,576,1375066720.3%
Q3 2020189$2.1B64,076,3043375440.1%
Q2 2020166$1.5B58,387,4052349600.1%
Q1 2020164$1.5B60,306,6221955590.1%
Q4 2019179$1.5B53,729,7952953670.1%
Q3 2019187$1.3B54,361,0844167560.1%
Q2 2019195$1.4B48,045,9896370490.5%
Q1 2019150$988.9M39,353,1383642540.4%
Q4 2018125$474.0M37,669,9393120.1%